Breaking news and updates from Nigeria's pharmacy profession.
Health insurance can reduce the financial burden of healthcare, but coverage alone does not guarantee seamless access. Understanding your plan, provider network, authorisation requirements and complaint channels can help subscribers protect their rights.
Nigeria is strengthening its response to diphtheria through vaccination, surveillance and community engagement. But with millions of children still unvaccinated, reaching those missed by routine immunisation remains a major challenge.
The Department of Pharmaceutical Services, ABUTH, Shika–Zaria, has held a workshop for pharmacy preceptors, focusing on ethics, mentorship and the responsibility of experienced pharmacists in developing competent future practitioners.
NAFDAC Director-General Prof. Mojisola Adeyeye has highlighted regulatory reforms, rising local manufacturing and new investment partnerships as key developments in Nigeria’s health-products sector.
The International Pharmaceutical Federation has called for stronger pharmacist involvement in preventing and reducing harms linked to non-medicinal psychoactive substance use, including early identification, treatment support, overdose prevention and evidence-informed harm reduction.
The National Orientation Agency has taken its campaign against drug abuse, violence, sexual harassment and rights violations to Mabushi, urging stronger community action to protect young people and promote accountability.
Nigeria recorded 253 Lassa fever deaths by epidemiological week 34 of 2026, compared with 160 deaths at the same point in 2025, while the case fatality rate increased from 18.7% to 24%.
Global tobacco-leaf production declined by nearly 19% between 2012 and 2024, but Africa recorded an almost 9% increase, while cigarette imports more than doubled, according to a new WHO analysis.
The International Pharmaceutical Federation has launched the FIP Montreal Declaration on NCDs, calling for stronger integration of pharmacists into primary healthcare, prevention, screening and long-term management of chronic diseases.
The Federal Government has called for rigorous research, stronger regulation and quality assurance for traditional medicines, stressing that cultural acceptance alone cannot establish scientific evidence of safety, efficacy or quality.
The Pharmacy Council of Nigeria sealed 430 pharmaceutical premises in Yobe State after inspecting 601 facilities across 10 local government areas during a four-day enforcement exercise
The US FDA has approved Mounjaro (tirzepatide) to reduce major cardiovascular events in adults with type 2 diabetes at high cardiovascular risk, expanding the medicine’s role beyond glycaemic control.
